
CPHI Milan 2026
10/2026 – 10/2026
Windgap empowers patients and enables new medicines through improved self-administration and at-home injection. Its dual-cartridge autoinjectors address challenges facing leading pharmaceutical companies and patients, including simplifying complex preparations, enabling long-acting injectables, and transitioning to subcutaneous drug delivery, with proprietary mixing and delivery technology ensuring precise, compact and user-friendly administration; through strategic collaborations with pharma partners, Windgap accelerates advanced therapies, improves patient outcomes, and meets the challenges of complex drug delivery.

No comments available.
Leave your rating & comment